Hawkins RE - Search Results

1

Engineering T-cells with antibody-based chimeric receptors for effective cancer therapy.

Thistlethwaite F, Mansoor W, Gilham DE, Hawkins RE. Thistlethwaite F, et al. Among authors: hawkins re. Curr Opin Mol Ther. 2005 Feb;7(1):48-55. Curr Opin Mol Ther. 2005. PMID: 15732529 Review.

2

Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumors.

Jiang HR, Gilham DE, Mulryan K, Kirillova N, Hawkins RE, Stern PL. Jiang HR, et al. Among authors: hawkins re. J Immunol. 2006 Oct 1;177(7):4288-98. doi: 10.4049/jimmunol.177.7.4288. J Immunol. 2006. PMID: 16982863

3

Building better chimeric antigen receptors for adoptive T cell therapy.

Bridgeman JS, Hawkins RE, Hombach AA, Abken H, Gilham DE. Bridgeman JS, et al. Among authors: hawkins re. Curr Gene Ther. 2010 Apr;10(2):77-90. doi: 10.2174/156652310791111001. Curr Gene Ther. 2010. PMID: 20222863 Review.

4

Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.

Lipowska-Bhalla G, Gilham DE, Hawkins RE, Rothwell DG. Lipowska-Bhalla G, et al. Among authors: hawkins re. Cancer Immunol Immunother. 2012 Jul;61(7):953-62. doi: 10.1007/s00262-012-1254-0. Epub 2012 Apr 22. Cancer Immunol Immunother. 2012. PMID: 22527245 Free PMC article. Review.

5

Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3zeta-based chimeric immune receptors.

Gilham DE, O'Neil A, Hughes C, Guest RD, Kirillova N, Lehane M, Hawkins RE. Gilham DE, et al. Among authors: hawkins re. J Immunother. 2002 Mar-Apr;25(2):139-51. doi: 10.1097/00002371-200203000-00002. J Immunother. 2002. PMID: 12074044

6

Engineering T cells for cancer therapy.

Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE. Mansoor W, et al. Among authors: hawkins re. Br J Cancer. 2005 Nov 14;93(10):1085-91. doi: 10.1038/sj.bjc.6602839. Br J Cancer. 2005. PMID: 16251873 Free PMC article. Review.

7

Development of adoptive cell therapy for cancer: a clinical perspective.

Hawkins RE, Gilham DE, Debets R, Eshhar Z, Taylor N, Abken H, Schumacher TN, ATTACK Consortium. Hawkins RE, et al. Hum Gene Ther. 2010 Jun;21(6):665-72. doi: 10.1089/hum.2010.086. Hum Gene Ther. 2010. PMID: 20408760 Review.

8

Cancer vaccines: a clinical perspective.

Dangoor A, Thistlethwaite F, Hawkins R. Dangoor A, et al. Br J Hosp Med (Lond). 2006 Jul;67(7):365-9. doi: 10.12968/hmed.2006.67.7.21621. Br J Hosp Med (Lond). 2006. PMID: 16884151 Review. No abstract available.

9

Vaccine and antibody-directed T cell tumour immunotherapy.

Dermime S, Gilham DE, Shaw DM, Davidson EJ, Meziane el-K, Armstrong A, Hawkins RE, Stern PL. Dermime S, et al. Among authors: hawkins re. Biochim Biophys Acta. 2004 Jul 6;1704(1):11-35. doi: 10.1016/j.bbcan.2004.03.002. Biochim Biophys Acta. 2004. PMID: 15238242 Review.

10

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.

Guest RD, Hawkins RE, Kirillova N, Cheadle EJ, Arnold J, O'Neill A, Irlam J, Chester KA, Kemshead JT, Shaw DM, Embleton MJ, Stern PL, Gilham DE. Guest RD, et al. Among authors: hawkins re. J Immunother. 2005 May-Jun;28(3):203-11. doi: 10.1097/01.cji.0000161397.96582.59. J Immunother. 2005. PMID: 15838376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters